Cargando…
A new strategy for osteoarthritis therapy: Inhibition of glycolysis
Osteoarthritis (OA) is a common degenerative disease of the joints. It is primarily caused by age, obesity, mechanical damage, genetics, and other factors, leading to cartilage degradation, synovial inflammation, and subchondral sclerosis with osteophyte formation. Many recent studies have reported...
Autores principales: | Tan, Chunmei, Li, Lanqing, Han, Juanjuan, Xu, Kang, Liu, Xianqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685317/ https://www.ncbi.nlm.nih.gov/pubmed/36438808 http://dx.doi.org/10.3389/fphar.2022.1057229 |
Ejemplares similares
-
Noncoding RNAs in the Glycolysis of Ovarian Cancer
por: Zhang, Chunmei, et al.
Publicado: (2022) -
Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis
por: Du, Yishan, et al.
Publicado: (2022) -
Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis
por: Chen, Weimou, et al.
Publicado: (2021) -
Phytochemicals targeting glycolysis in colorectal cancer therapy: effects and mechanisms of action
por: Zhan, Lu, et al.
Publicado: (2023) -
The roles of glycolysis in osteosarcoma
por: Feng, Zuxi, et al.
Publicado: (2022)